Pernod Ricard Shares Tumble Following Unexpected Downgrade

Shares of French spirits giant Pernod Ricard experienced a significant sell-off yesterday. The decline was triggered by a surprise downgrade from investment bank Morgan Stanley, which shifted its rating from “Equalweight” to “Underweight.” Concurrently, the bank reduced its price target for the stock from €90 to €85. During the trading session, the equity fell by as much as 2.7 percent, ultimately closing at €92 per share.

Gloomy 2026 Forecasts Drive Pessimism

The downgrade is rooted in a notably more pessimistic outlook for Pernod Ricard’s 2026 fiscal year. Morgan Stanley’s analysts now project a 2 percent decline in organic sales, a stark contrast to the broader market consensus which anticipated a far more modest dip of 0.3 percent. This downward revision is primarily attributed to ongoing inventory adjustments in the company’s key markets: the United States, India, and China. These three regions collectively represent 43 percent of the group’s total revenue. The bank also warned that the first quarter of FY2026 is likely to be weaker than the same period a year prior.

The projections for earnings are even more severe. The bank forecasts a 3.3 percent drop in organic EBIT (earnings before interest and taxes), drastically undercutting the market’s expectation of a 0.1 percent decrease. This would equate to a margin contraction of 35 basis points. These forecasts come despite Pernod Ricard’s successful €450 million cost-saving initiative last year and the announcement of a new, ambitious €1 billion efficiency program set to run through 2029. Morgan Stanley anticipates significantly lower savings from these measures in 2026.

Should investors sell immediately? Or is it worth buying Pernod Ricard.?

• Reduced Price Target: Lowered from €90 to €85
• Sales Forecast: -2% vs. a consensus of -0.3%
• EBIT Forecast: -3.3% vs. a consensus of -0.1%

Strategic Pivot Under Scrutiny

This recent analyst action follows disappointing full-year results announced in August, which already showed declining revenue and profit. In response, the company has initiated a strategic overhaul. In the critical U.S. market, the distribution strategy has been completely revamped, including the creation of new divisions dedicated to ready-to-drink beverages and growth markets. Furthermore, Pernod Ricard has sold its Indian whisky brand Imperial Blue, a move intended to sharpen its focus on more profitable premium products. This divestment will reduce India’s contribution to total revenue from 13 percent to 11 percent.

The question now is whether the comprehensive “Tomorrow 2” restructuring plan, with its promised €1 billion in savings, can successfully steer a turnaround. The measures are designed to create a more agile organization and concentrate efforts on high-end brands. However, the current concerns from analysts regarding inventory levels and the projected speed of the profit recovery present significant headwinds.

Outlook: Dividend and Shareholder Meeting in Focus

Market attention now turns to the company’s Annual General Meeting scheduled for October 27. A stable dividend of €4.70 per share is on the agenda for approval. Prior to Morgan Stanley’s downgrade, the average price target among 19 analysts covering the stock stood at approximately €110. The new, far more conservative target of €85 signals a major reassessment of the company’s near-term prospects. The current share price of €92 reflects these heightened market risks and positions the stock at the lower end of expectations.